E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 12 740 KRW -2% Market Closed
Market Cap: 465.4B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one EuBiologics Co Ltd stock under the Base Case scenario is 17 421.92 KRW. Compared to the current market price of 12 740 KRW, EuBiologics Co Ltd is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
17 421.92 KRW
Undervaluation 27%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation Backtest
EuBiologics Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EuBiologics Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EuBiologics Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about EuBiologics Co Ltd

Provide an overview of the primary business activities
of EuBiologics Co Ltd.

What unique competitive advantages
does EuBiologics Co Ltd hold over its rivals?

What risks and challenges
does EuBiologics Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for EuBiologics Co Ltd.

Provide P/S
for EuBiologics Co Ltd.

Provide P/E
for EuBiologics Co Ltd.

Provide P/OCF
for EuBiologics Co Ltd.

Provide P/FCFE
for EuBiologics Co Ltd.

Provide P/B
for EuBiologics Co Ltd.

Provide EV/S
for EuBiologics Co Ltd.

Provide EV/GP
for EuBiologics Co Ltd.

Provide EV/EBITDA
for EuBiologics Co Ltd.

Provide EV/EBIT
for EuBiologics Co Ltd.

Provide EV/OCF
for EuBiologics Co Ltd.

Provide EV/FCFF
for EuBiologics Co Ltd.

Provide EV/IC
for EuBiologics Co Ltd.

Show me price targets
for EuBiologics Co Ltd made by professional analysts.

What are the Revenue projections
for EuBiologics Co Ltd?

How accurate were the past Revenue estimates
for EuBiologics Co Ltd?

What are the Net Income projections
for EuBiologics Co Ltd?

How accurate were the past Net Income estimates
for EuBiologics Co Ltd?

What are the EPS projections
for EuBiologics Co Ltd?

How accurate were the past EPS estimates
for EuBiologics Co Ltd?

What are the EBIT projections
for EuBiologics Co Ltd?

How accurate were the past EBIT estimates
for EuBiologics Co Ltd?

Compare the revenue forecasts
for EuBiologics Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of EuBiologics Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of EuBiologics Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of EuBiologics Co Ltd compared to its peers.

Compare the P/E ratios
of EuBiologics Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing EuBiologics Co Ltd with its peers.

Analyze the financial leverage
of EuBiologics Co Ltd compared to its main competitors.

Show all profitability ratios
for EuBiologics Co Ltd.

Provide ROE
for EuBiologics Co Ltd.

Provide ROA
for EuBiologics Co Ltd.

Provide ROIC
for EuBiologics Co Ltd.

Provide ROCE
for EuBiologics Co Ltd.

Provide Gross Margin
for EuBiologics Co Ltd.

Provide Operating Margin
for EuBiologics Co Ltd.

Provide Net Margin
for EuBiologics Co Ltd.

Provide FCF Margin
for EuBiologics Co Ltd.

Show all solvency ratios
for EuBiologics Co Ltd.

Provide D/E Ratio
for EuBiologics Co Ltd.

Provide D/A Ratio
for EuBiologics Co Ltd.

Provide Interest Coverage Ratio
for EuBiologics Co Ltd.

Provide Altman Z-Score Ratio
for EuBiologics Co Ltd.

Provide Quick Ratio
for EuBiologics Co Ltd.

Provide Current Ratio
for EuBiologics Co Ltd.

Provide Cash Ratio
for EuBiologics Co Ltd.

What is the historical Revenue growth
over the last 5 years for EuBiologics Co Ltd?

What is the historical Net Income growth
over the last 5 years for EuBiologics Co Ltd?

What is the current Free Cash Flow
of EuBiologics Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for EuBiologics Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
EuBiologics Co Ltd

Current Assets 41.8B
Cash & Short-Term Investments 9.9B
Receivables 12.1B
Other Current Assets 19.8B
Non-Current Assets 110B
Long-Term Investments 15.4B
PP&E 70.1B
Intangibles 17.6B
Other Non-Current Assets 7B
Current Liabilities 25.7B
Accounts Payable 635.7m
Accrued Liabilities 677.3m
Short-Term Debt 8.7B
Other Current Liabilities 15.7B
Non-Current Liabilities 14.7B
Long-Term Debt 4.3B
Other Non-Current Liabilities 10.4B
Efficiency

Earnings Waterfall
EuBiologics Co Ltd

Revenue
86.1B KRW
Cost of Revenue
-37.9B KRW
Gross Profit
48.2B KRW
Operating Expenses
-42.8B KRW
Operating Income
5.4B KRW
Other Expenses
-7.2B KRW
Net Income
-1.8B KRW

Free Cash Flow Analysis
EuBiologics Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

EuBiologics Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
Exceptional Revenue Growth Forecast
42/100
Profitability
Score

EuBiologics Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

EuBiologics Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
70/100
Solvency
Score

EuBiologics Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
EuBiologics Co Ltd

Wall Street analysts forecast EuBiologics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EuBiologics Co Ltd is 14 280 KRW with a low forecast of 14 140 KRW and a high forecast of 14 700 KRW.

Lowest
Price Target
14 140 KRW
11% Upside
Average
Price Target
14 280 KRW
12% Upside
Highest
Price Target
14 700 KRW
15% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EuBiologics Co Ltd?

Click here to dive deeper.

Dividends

EuBiologics Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for EuBiologics Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

EuBiologics Co Ltd

Country

Korea

Industry

Biotechnology

Market Cap

464.4B KRW

Dividend Yield

0%

Description

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

Contact

SEOUL
Seoul
8F, Seongdo Bldg., 207, Dosan-daero, Gangnam-gu
+8225726675
www.eubiologics.com

IPO

2017-01-24

Employees

323

Officers

CEO & Head of Business Planning
Mr. Yeong-Ok Baik
VP & Head of Production Plan
Mr. Kyeong-Ho Min
Managing Director of Production Division 2
Mr. Young-Shin Park
VP & Head of Research and Development
Mr. Chan-kyu Lee
Managing Director of Quality Management Department
Jeong-Sup Shin
Executive Director & Head of Business Management Division
Jun-kwang Bae
Show More
Managing Director of Production Planning Headquarters
Shin-Hee Jeon
Managing Director of Production Division 1
Young-hee Shin
Show Less

See Also

Discover More
What is the Intrinsic Value of one EuBiologics Co Ltd stock?

The intrinsic value of one EuBiologics Co Ltd stock under the Base Case scenario is 17 421.92 KRW.

Is EuBiologics Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12 740 KRW, EuBiologics Co Ltd is Undervalued by 27%.

Back to Top